Two Stocks Under Discussion: Alta Mesa Resources, Inc. (NASDAQ:AMR), Ampio Pharmaceuticals, Inc. (NYSE:AMPE)

stock updates

Alta Mesa Resources, Inc. (NASDAQ:AMR)

Alta Mesa Resources, Inc. (NASDAQ:AMR) closed at $0.3 on the last trading session with an increase of 0%, whereas, it previously closed at $0.3. The company has a market capitalization of $51.06 Million. The company traded shares of 0 on the trading day while its three month average volume stands at 2.96 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Alta Mesa Resources, Inc. (NASDAQ:AMR) produced diluted EPS of -0.11. The EPS estimate for next year as estimated by analysts is at 0.1 while EPS for next quarter is estimated at 0.04. Earnings per Share growth for this year is reported at 0, while the analysts estimated the EPS growth for next year at 0.1% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 0%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Alta Mesa Resources, Inc. (NASDAQ:AMR) is at 0 while the forward p/e is at 2.89. The P/S or Price to Sales ratio of Alta Mesa Resources, Inc. (NASDAQ:AMR) stands at 0.15 and Price to Book or P/B for the most recent quarter stands at 0.04. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Alta Mesa Resources, Inc. (NASDAQ:AMR) are reported at 0.6 and 0.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Alta Mesa Resources, Inc. (NASDAQ:AMR) stands at 0, 0 and 0 respectively

The trailing twelve month Revenue of Alta Mesa Resources, Inc. (NASDAQ:AMR) is reported at 334.2 Million with income of -18900000. The outstanding shares of Alta Mesa Resources, Inc. (NASDAQ:AMR) are 171.29 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 0 in the last six months. The insider ownership for the shares of Alta Mesa Resources, Inc. (NASDAQ:AMR) is ticked at 0.1%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Alta Mesa Resources, Inc. (NASDAQ:AMR) is the Mean Target Price estimated by the analysts which stands at 2.39. The 52 week high of Alta Mesa Resources, Inc. (NASDAQ:AMR) is placed at 8.70 and 52 week low is standing at 0.20.

Performance wise the shares of Alta Mesa Resources, Inc. (NASDAQ:AMR) fell down -20.1% for the week, it also fell -64.43% for the monthly performance, while for the quarter it went up -81.37%. The shares decrease -93.64% for the half year and plummeted for the Year-To-Date performance. The shares of Alta Mesa Resources, Inc. (NASDAQ:AMR) shrinked -96.22% for the yearly performance.

Ampio Pharmaceuticals, Inc. (NYSE:AMPE)

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) closed at $0.62 on the last trading session with an increase of 0%, whereas, it previously closed at $0.62. The company has a market capitalization of $69.09 Million. The company traded shares of 0 on the trading day while its three month average volume stands at 769.05 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) produced diluted EPS of -0.23. The EPS estimate for next year as estimated by analysts is at 0 while EPS for next quarter is estimated at 0. Earnings per Share growth for this year is reported at -123, while the analysts estimated the EPS growth for next year at 0% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -18.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) stands at 0 and Price to Book or P/B for the most recent quarter stands at 31.01. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) are reported at 5.3 and 5.3 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Ampio Pharmaceuticals, Inc. (NYSE:AMPE) stands at 381, -489.2 and 0 respectively

The trailing twelve month Revenue of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) is reported at 0 with income of -10700000. The outstanding shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) are 111.42 Million. The institutional Ownership of the shares of 24.5 stands at 0.80%, this figure is increased 5.23 in the last six months. The insider ownership for the shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) is ticked at 0.5%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Ampio Pharmaceuticals, Inc. (NYSE:AMPE) is the Mean Target Price estimated by the analysts which stands at 14. The 52 week high of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) is placed at 3.89 and 52 week low is standing at 0.35.

Performance wise the shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) fell down -9.42% for the week, it also rise 10.2% for the monthly performance, while for the quarter it went up -1.6%. The shares increase 13.76% for the half year and flew up for the Year-To-Date performance. The shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) shrinked -75.1% for the yearly performance.